US: CBIA - Canopus BioPharma Incorporated

Yield per half year: -50%
Dividend yield: 0.00%
Sector: Communication Services

Share chart Canopus BioPharma Incorporated

Extended chart Simple chart
Financial Markets by TradingView

About Canopus BioPharma Incorporated

Canopus BioPharma Incorporated, a pharmaceutical research company, provides pharmaceutical products and assay methods to patients suffering from infectious, cancer, and addiction diseases. It also provides antivirals, radiation protection products, oncology products, bio-barcode assays, camelidae blood products, and neutraceutricals. The company was founded in 1996 as Canopus Corporation and changed its name in 2007. Canopus BioPharma Incorporated is based in Santa Monica, California.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

Industry Media
Sector Communication Services
Валюта usd
Валюта отчета usd
Цена ао 0.0001
Change price per day: 0% (0.0001)
Change price per week: 0% (0.0001)
Change price per month: 0% (0.0001)
Change price per 3 month: 0% (0.0001)
Change price per half year: -50% (0.0002)
Change price per year: -66.67% (0.0003)
Change price per 3 year: -99.75% (0.04)
Change price per 5 year: -99.93% (0.14)
Change price per year to date: -50% (0.0002)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Total: 2.5

Efficiency

Title Value Grade
ROA, % 0 0
ROE, % 0 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % 604.27 10
Yield EPS, % -38.25 0
Total: 3.2
More



Head Job title Payment Year of birth
Mr. Patrick T. Prendergast Chairman & CEO
Mr. Leo J. Prendergast COO & Director
Mr. Andries J. Lategan B.Pharm, M.Sc, Ph.D. Chief Scientific Officer
Ms. Elizabeth Shanahan B.Sc. (Hon) President of Oncology Division

Address: United States, Santa Monica, 233 Wilshire Boulevard - open in Google maps, open in Yandex maps